Skip to main content
NCBI home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1999 Nov;36(11):819–822.

Strategies for screening for hereditary non-polyposis colorectal cancer

A Loukola 1, A de la Chapelle 1, L Aaltonen 1
PMCID: PMC1734266  PMID: 10544224

Abstract

Germline mutations in DNA mismatch repair genes (MLH1, MSH2, PMS1, PMS2, and MSH6) predispose to hereditary non-polyposis colorectal cancer (HNPCC). In the absence of pathognomonic clinical features, diagnosis of HNPCC is often based on family history. Microsatellite instability (MSI) analysis has successfully been used for screening colorectal cancer patients for HNPCC. The aim of this study was to evaluate the feasibility of a recently introduced logistical model based on family history data in detecting HNPCC patients with germline mutations. A series of 509 kindreds with a proband with colorectal cancer was studied. MSI analysis and subsequent germline mutation analysis (MLH1 and MSH2) in MSI positive patients had been performed previously. Of the 509 patients, 63 (12%) were MSI positive and 10 (2%) had a germline mutation in MLH1 or MSH2. The power of the logistical model was tested to determine its value in predicting the probability of a germline mutation. The model proposed a high probability in three out of 10 mutation positive cases when data on cancer in first degree relatives were considered (typically three generation pedigrees, consisting, on average, of eight people). Using extended pedigrees and family cancer data in the 10 mutation positive kindreds (an average of 38 family members available), the model suggested high probabilities in seven out of 10 mutation positive cases. We conclude that for the model to predict germline mutation cases, extensive pedigrees and family history data are required. When screening colorectal cancer patients for HNPCC, a model using a combination of family information and MSI has optimal specificity and sensitivity.


Keywords: HNPCC; screening; MSI; colon cancer

Full Text

The Full Text of this article is available as a PDF (76.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltonen L. A., Peltomäki P., Mecklin J. P., Järvinen H., Jass J. R., Green J. S., Lynch H. T., Watson P., Tallqvist G., Juhola M. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res. 1994 Apr 1;54(7):1645–1648. [PubMed] [Google Scholar]
  2. Aaltonen L. A., Salovaara R., Kristo P., Canzian F., Hemminki A., Peltomäki P., Chadwick R. B., Käriäinen H., Eskelinen M., Järvinen H. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998 May 21;338(21):1481–1487. doi: 10.1056/NEJM199805213382101. [DOI] [PubMed] [Google Scholar]
  3. Aarnio M., Sankila R., Pukkala E., Salovaara R., Aaltonen L. A., de la Chapelle A., Peltomäki P., Mecklin J. P., Järvinen H. J. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer. 1999 Apr 12;81(2):214–218. doi: 10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  4. Douglas F. S., O'Dair L. C., Robinson M., Evans D. G., Lynch S. A. The accuracy of diagnoses as reported in families with cancer: a retrospective study. J Med Genet. 1999 Apr;36(4):309–312. [PMC free article] [PubMed] [Google Scholar]
  5. Dunlop M. G., Farrington S. M., Carothers A. D., Wyllie A. H., Sharp L., Burn J., Liu B., Kinzler K. W., Vogelstein B. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997 Jan;6(1):105–110. doi: 10.1093/hmg/6.1.105. [DOI] [PubMed] [Google Scholar]
  6. Järvinen H. J., Mecklin J. P., Sistonen P. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 1995 May;108(5):1405–1411. doi: 10.1016/0016-5085(95)90688-6. [DOI] [PubMed] [Google Scholar]
  7. Kinzler K. W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996 Oct 18;87(2):159–170. doi: 10.1016/s0092-8674(00)81333-1. [DOI] [PubMed] [Google Scholar]
  8. Lynch H. T., Smyrk T. C. Identifying hereditary nonpolyposis colorectal cancer. N Engl J Med. 1998 May 21;338(21):1537–1538. doi: 10.1056/NEJM199805213382109. [DOI] [PubMed] [Google Scholar]
  9. Mecklin J. P., Järvinen H. J., Hakkiluoto A., Hallikas H., Hiltunen K. M., Härkönen N., Kellokumpu I., Laitinen S., Ovaska J., Tulikoura J. Frequency of hereditary nonpolyposis colorectal cancer. A prospective multicenter study in Finland. Dis Colon Rectum. 1995 Jun;38(6):588–593. doi: 10.1007/BF02054116. [DOI] [PubMed] [Google Scholar]
  10. Parker S. L., Tong T., Bolden S., Wingo P. A. Cancer statistics, 1996. CA Cancer J Clin. 1996 Jan-Feb;46(1):5–27. doi: 10.3322/canjclin.46.1.5. [DOI] [PubMed] [Google Scholar]
  11. Vasen H. F., van Ballegooijen M., Buskens E., Kleibeuker J. K., Taal B. G., Griffioen G., Nagengast F. M., Menko F. H., Meera Khan P. A cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer. 1998 May 1;82(9):1632–1637. [PubMed] [Google Scholar]
  12. Wijnen J. T., Vasen H. F., Khan P. M., Zwinderman A. H., van der Klift H., Mulder A., Tops C., Møller P., Fodde R. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med. 1998 Aug 20;339(8):511–518. doi: 10.1056/NEJM199808203390804. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES